These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19513844)

  • 1. Increased oxidative stress, decreased total antioxidant capacity, and iron overload in untreated patients with chronic hepatitis C.
    Venturini D; Simão AN; Barbosa DS; Lavado EL; Narciso VE; Dichi I; Dichi JB
    Dig Dis Sci; 2010 Apr; 55(4):1120-7. PubMed ID: 19513844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of increased oxidative stress and ferritin in reducing the effectiveness of therapy in chronic hepatitis C patients.
    Chiou YL; Chen YH; Ke T; Ko WS
    Clin Biochem; 2012 Nov; 45(16-17):1389-93. PubMed ID: 22760008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum iron overload, AST:ALT ratio and log
    Owiredu WKBA; Brenya PK; Osei Y; Laing EF; Okrah CO; Obirikorang C; Anto EO; Acheampong E; Donkor S
    BMC Res Notes; 2019 Dec; 12(1):802. PubMed ID: 31831048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum fatty acids, antioxidants, and treatment response in hepatitis C infection: greater polyunsaturated fatty acid and antioxidant levels in hepatitis C responders.
    Irmisch G; Hoeppner J; Thome J; Richter J; Fernow A; Reisinger EC; Lafrenz M; Loebermann M
    J Clin Lipidol; 2011; 5(4):288-93. PubMed ID: 21784374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome.
    Simão AN; Dichi JB; Barbosa DS; Cecchini R; Dichi I
    Nutrition; 2008; 24(7-8):675-81. PubMed ID: 18499396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants.
    Barton JC; Barton JC; Adams PC
    Ann Hepatol; 2017; 16(5):802-811. PubMed ID: 28809726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).
    Madan K; Bhardwaj P; Thareja S; Gupta SD; Saraya A
    J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
    Girelli CM; Mirata C; Casiraghi A
    Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
    Alexander J; Tung BY; Croghan A; Kowdley KV
    Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of oxidative stress markers is dependent on vitamin D levels in patients with chronic hepatitis C.
    de Almeida JP; Liberatti LS; Barros FE; Kallaur AP; Lozovoy MA; Scavuzzi BM; Panis C; Reiche EM; Dichi I; Simão AN
    Nutrition; 2016 Mar; 32(3):362-7. PubMed ID: 26847403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron and proinflammatory cytokines in chronic hepatitis C virus infection.
    López-Prieto J; González-Reimers E; Alemán-Valls MR; de la Vega-Prieto MJ; Abreu-González P; Pelazas-González R; Hernández-Luis R; Jorge-Ripper C; Santolaria-Fernández F
    Biol Trace Elem Res; 2013 Oct; 155(1):5-10. PubMed ID: 23892696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: influence of serum ferritin levels.
    Chen WT; Lin YF; Yu FC; Kao WY; Huang WH; Yan HC
    Am J Kidney Dis; 2003 Jul; 42(1):158-66. PubMed ID: 12830468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
    Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.
    Uraz S; Aygun C; Sonsuz A; Ozbay G
    Dig Dis Sci; 2005 May; 50(5):964-9. PubMed ID: 15906776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
    Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
    Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis C.
    Di Fazio I; Motta M; Musumeci S; Neri S; Pistone G; Malaguarnera M
    J Interferon Cytokine Res; 2004 Oct; 24(10):594-9. PubMed ID: 15626156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.